- Smallest US Businesses Borrowing Again: PayNet
- Wave of Debt Payments Facing US Government
- US Job Losses to Bottom out Next Quarter: NABE
- Little Sign of Inflation on the Horizon: IMF
- Kraft Weighs Higher Cadbury Bid as Rivals Circle
- MBS Program Should be Extended: Fed's Bullard
- Warren Buffett, Bill Gates 'Walk & Talk' At Columbia
- Microsoft, News Corp Weigh Online News Pact
- Senate Democrats at Odds Over Health Care Bill
- CNBC VIDEO: Warren Buffett & Bill Gates 'Walk & Talk' at Columbia University
- U.S. Stocks Slip, Dollar Rises
- How Stock Investors Can Play Holiday Travel
- Time Lapse World Series Is A Great Play
- Hirschhorn: Greed...or Fear
- My Top 10 Tech Toys for the Holidays
- iPhone a Better Gaming Platform Than Android?
- May Day For Dendreon
- 100% Mortgage Financing From USDA
- French ship Russia wants to buy in St Petersburg
- Program to help truckers attracts drug smugglers
- Germany's Merck will expand R&D in China
- HP likely buoyed by PC recovery but worries remain
- JP Morgan names new China CEO
- Bio-fuel growth raises concerns about forests
- Taiwan jobless rate drops in October
- New olive planting method prompts California boom
- New olive planting method prompts Calif. oil boom
Text Size 
NEW YORK - XStream Systems Inc. plans to offer 2.5 million shares in an initial public offering, according to a Securities and Exchange Commission filing Thursday.
XStream's molecular screening technology is used to screen the structure of hidden materials, with a key goal being the identification of counterfeit pharmaceuticals.
The Sebastian, Fla., company expects to price the offering at $15 per share, for a total estimated offering amount of $37.5 million. The offering breaks down to 2 million shares plus up to an additional 500,000 shares to cover over subscriptions.
The company is also offering $6 million in convertible debentures.
XStream plans on using proceeds to repay notes and fund operations.
"Our technology enables forensic analysis to take place where it is needed, by anyone who needs to authenticate or detect materials," the company said in a statement.
The company's countertop XT250TM Material Identification System can be used outside a laboratory by nontechnical personnel to authenticate pharmaceutical inventories, even when sealed in their original packaging. The products are primarily aimed at businesses and government agencies.
The company said it will apply to list its common stock on the NASDAQ Capital Market.
Print
Email
- Technology can make or break a fortune in the world of alternative energy.
- Warren Buffett and Bill Gates discuss the economy and other subjects with CNBC's Becky Quick.
- Many people are facing the holidays with substantially smaller incomes. Here’s how some are adapting.
- Jim Cramer is a proponent of stocks that pay healthy dividends, and here are his top five dividend plays.
- The homebuyer's tax credit jacked sales for a while, but 2010 is looking weak. Now what?
- CNBC’s technology reporter Jim Goldman guides you through the best gadgets to buy this holiday season.
Data is a real-time snapshot *Data is delayed at least 15 minutes